L-Isoleucine CAS NO.73-32-5

 Product Description

Introduction:
L-Isoleucine is an amino acid, one of three known as branched chain amino acids (BCAAs). The others are L-Leucine and L-Valine. L-Isoleucine is an isomer of Leucine. It is important in the regulation of blood sugar, and also helps increase energy level. L-Isoleucine can be obtained through the foods you eat or supplements. Some of these foods include meat, fish, eggs, beans, nuts and seeds.

Function:
1.Food grade
L-Isoleucine is used for all kinds of amino acid nutraceuticals, sports and fitness nourishment, amino acid functional beverage. And as an important the food additive, used to strengthen all kinds of food, and improve the nutrition value of food.

2.Pharmaceutical grade
L-Isoleucine is as an amino acid fluid infusion, can replace sugar metabolism and provide energy, it is more precious amino acid API, treatment of special amino acid type of drugs such as liver, and liver spirit liquid

Wuhan BJM Pharm Inc. was found in 2013, located in Hubei Province, where has long history, rich culture, convenient traffic, beautiful environment and preferential policy.

We have two factories in Dezhou , Shandong and Xianning, Hubei. The factory covers an area of 48,000 square meters with the building area of 26,000 square meters. We are specialized in the manufacture of pharmaceutical intermediates and cosmetic additives with good inspection equipments and innovative R & D capability.

In 2006, We established Lingxian Microworld Chemical New Material Co,.Ltd.

In 2008, We passed ISO quality system certificate

In 2013, We established Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd , and obtain self-operation Import & Export right, mainly responsible for domestic and foreign business. At the same time, we set up R&D lab in Wuhan,Hubei province, can undertake various custom synthesis of intermediates and APIs.

In 2016,  obtain a registered trademark “ BJM ”.

In 2017, we applied for the invention patent of TRIS, and in 2018, we applied for the invention patent of ERDOSTAN intermediate（DL-HOMO）. At present, we have6 patents passed the preliminary examination, and 4 patents are under examination and approval.

In 2019, we purchased a R&D and office building with a total area of 2500 square meters, as our headquarters in Wuhan.

In 2020, we registered BJM Pharm Yunmeng Co., Ltd,  and the new production base settled in Geputan chemical park with  a total area of 50000 square meters.

We are specialized in the R&D ,production and sales of Erdosteine ,Pirfenidone, Telmisartan, Letrozole , Sitagliptin phosphate, Dapagliflozin , Tris , IPTG and related intermediates.

We stick to the principle as: people-oriented, customer first, Hope to establish a win-win business relationship with all friends.